A critical advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently lost in several types of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research